http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
Mechanisms of angiogenesis: potential therapeutic targets -- Angiogenesis and ischemia -- The role of smooth muscle cells and pericytes in angiogenesis -- Integrin αvbeta-3 in metastasis, vascular remodeling and angiogenesis -- PECAM-1 and angiogenesis -- Thrombospondin and angiogenesis -- The role of vascular endothelial growth factor in angiogenesis -- Regulation of angiogenesis by fibroblast growth factors -- Role of angiogenesis in wound healing -- Ocular neovascularization -- Anti-angiogenesis strategies: potential therapeutic implications -- Matrix metalloproteinase inhibitors in angiogenesis- mediated disorders with special emphasis on cancer -- Pharmaceutical development of an antiangiogenic drug-candidate: challenges and opportunities -- Surrogate endpoints as a measure of efficacy in clinical trials of angiogenesis inhibitors -- Lessons from clinical trials of anti-angiogenic drugs in the treatment of cancer.
Includes bibliographical references and index.